Myosin Therapeutics
Business Services · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
130 Scripps Way, Jupiter, Florida, 33458...Phone Number
(844) 696-7469Website
www.myosintherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Myosin Therapeutics
Myosin Therapeutics is a privately-held biopharmaceutical company dedicated to developing novel medications that target cellular motor proteins, addressing critical unmet medical needs. The company's focus includes therapies for central nervous system disorders and oncology, with a particular emphasis on glioblastoma and substance use disorders, such as methamphetamine use disorder. Their lead programs, MT-125 and MT-110, aim to treat these conditions through innovative small molecule modulators. Myosin Therapeutics strives to create therapies that go beyond symptom relief by directly targeting the root causes of diseases.Explore more
Myosin Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Myosin Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Myosin Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Myosin Therapeutics recently announced quarterly report
Check if Myosin Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Myosin Therapeutics
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Myosin Therapeutics had a recent Job posting/layoffs
Check out if Myosin Therapeutics is spiking on competitors!
Product Launch: Get notified when Myosin Therapeutics launches new products
Funding: Get notified immidiatlly once Myosin Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Myosin Therapeutics
Compare insights from companies similar to Myosin Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Myosin Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Myosin Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Myosin Therapeutics.
Myosin Therapeutics financials insights
Gather financial insights about Myosin Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Angel/Seed
$3M
Grant
$3M
2026
Grant
$2M
Myosin Therapeutics Tech Stack
A closer look at the technologies used by Myosin Therapeutics
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Funding
Funding
Funding
Funding
Project
Award, Spending/Investment
Myosin Therapeutics News & Media
Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial
JUPITER, Fla., March 24, 2026 /PRNewswire/ -- Myosin Therapeutics today announced that it has been awarded $2 million in funding from the Florida Department of Health through the Casey DeSantis Florida Cancer Innovation Fund (FCIF) to support the company's STAR-GBM Phase 1/2 clinical...Myosin Therapeutics Invited to Present at Two South Florida Life Sciences Conferences
JUPITER, Fla., March 9, 2026 /PRNewswire/ -- Myosin Therapeutics today announced it has been invited to present at two upcoming South Florida life sciences events highlighting emerging biotechnology innovation and regional industry growth. On March 10, the company will participate in the...Myosin Therapeutics Invited to Present at Biocom California's Global Partnering & Investor Conference
JUPITER, Fla., Jan. 29, 2026 /PRNewswire/ -- Myosin Therapeutics today announced it has been selected to present at Biocom California's Global Partnering & Investor Conference, taking place February 24–26, 2026 at The Lodge at Torrey Pines in La Jolla, California. In addition to...Myosin Therapeutics Receives FDA Fast Track Designation for MT-125 in Glioblastoma
JUPITER, Fla., Oct. 22, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies that modulate molecular motor proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Myosin Therapeutics
Sign Up For FreeTo access detailed company insights
Myosin Therapeutics is a privately-held biopharmaceutical company dedicated to developing novel medications that target cellular motor proteins, addressing critical unmet medical needs. The company's focus includes therapies for central nervous system disorders and oncology, with a particular emphasis on glioblastoma and substance use disorders, su... Read More
